TribLIVE

| Home


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

AGH heart specialists to join clinical trial

Daily Photo Galleries

Wednesday, March 14, 2012
 

Heart specialists at Allegheny General Hospital announced today that they will join a clinical trial investigating an implantable device designed to provide patients with coronary artery disease an early warning of an impending heart attack.

AGH is the only Pittsburgh area hospital testing the new device — the AngelMed Guardian System.

"Patient outcomes following heart attack are largely dependent upon how quickly the cardiac injury is diagnosed and therapeutic efforts are initiated to restore blood flow to the heart. Delays in that process can result in permanent damage to heart muscle," said Dr. David Lasorda, director of the hospital's division of Interventional cardiology and its principal investigator in the study.

The American Heart Association estimates that one of every five deaths in the United States is attributable to coronary heart disease. Furthermore, 50 percent of heart-attack fatalities occur within one hour of symptom onset and often before the patient even reaches the hospital.

 

 
 


Show commenting policy

Most-Read Stories

  1. Hotel boom sweeps city
  2. Americans support strict rules for drones in poll
  3. Michigan State defensive coordinator a Pitt coaching candidate
  4. Pitt: Football coach hire comes 1st, athletic director 2nd
  5. Steelers notebook: Polamalu, Taylor unlikely to play, Harrison ‘ready’
  6. News Alert
  7. Musician embraced education, photography
  8. High school roundup: No. 4 Bethel Park boys edge USC
  9. Greensburg high school roundup: Hempfield downs Penn-Trafford to stay unbeaten
  10. Washington County man dies following fire at apartment complex
  11. Brashear High ‘little libraries’ program rolls out
Subscribe today! Click here for our subscription offers.